Upgrade to Finviz Elite: Get our fastest platform speed, real-time data, and unlimited screening & charting. Start Free Trial

HIND

Vyome Holdings Inc

Feb 06 • 04:00PM ET

2.74

+0.44 19.13 %

Healthcare • Biotechnology • USA • NASD

Feb 06, 12:01 PMRecent funding completion for VT-1953 Phase 3 trial fueled intraday surge.

Scroll to Statements

Index	-	P/E	-	EPS (ttm)	-177.38	Insider Own	72.61%	Shs Outstand	5.56M	Perf Week	42.71%
Market Cap	15.47M	Forward P/E	-	EPS next Y	-0.82	Insider Trans	0.00%	Shs Float	1.55M	Perf Month	-19.65%
Enterprise Value	11.19M	PEG	-	EPS next Q	-0.34	Inst Own	1.18%	Short Float	5.24%	Perf Quarter	-54.07%
Income	-11.35M	P/S	3.69	EPS this Y	99.78%	Inst Trans	26.09%	Short Ratio	0.10	Perf Half Y	-74.63%
Sales	4.19M	P/B	6.02	EPS next Y	74.13%	ROA	-179.31%	Short Interest	0.08M	Perf YTD	-20.35%
Book/sh	0.46	P/C	2.71	EPS next 5Y	90.07%	ROE	-565.18%	52W High	336.33 -99.19%	Perf Year	-99.18%
Cash/sh	1.01	P/FCF	-	EPS past 3/5Y	90.62% 80.05%	ROIC	-447.26%	52W Low	1.75 56.57%	Perf 3Y	-99.99%
Dividend Est.	-	EV/EBITDA	-	Sales past 3/5Y	-16.19% 19.53%	Gross Margin	62.32%	Volatility	24.88% 15.00%	Perf 5Y	-100.00%
Dividend TTM	-	EV/Sales	2.67	EPS Y/Y TTM	89.18%	Oper. Margin	-128.75%	ATR (14)	0.42	Perf 10Y	-
Dividend Ex-Date	-	Quick Ratio	1.94	Sales Y/Y TTM	-48.74%	Profit Margin	-270.60%	RSI (14)	46.85	Recom	1.00
Dividend Gr. 3/5Y	- -	Current Ratio	1.94	EPS Q/Q	99.02%	SMA20	-0.21%	Beta	1.40	Target Price	15.00
Payout	-	Debt/Eq	0.02	Sales Q/Q	-98.49%	SMA50	-24.87%	Rel Volume	0.57	Prev Close	2.30
Employees	18	LT Debt/Eq	0.00	Earnings	Nov 18 BMO	SMA200	-72.84%	Avg Volume	830.19K	Price	2.74
IPO	Oct 06, 2016	Option/Short	No / Yes	EPS/Sales Surpr.	-2736.36% -	Trades		Volume	474,450	Change	19.13%

Feb-02-26 07:00AM	Vyome Successfully Capitalizes All VT-1953 Funding Requirements For Initial Phase 3 Results (Business Wire) +14.58%
Jan-27-26 08:00AM	Independent Analyst Values Vyomes VT-1953 at USD 1 Billion Upon Successful Completion of Phase 3 Study (Business Wire)
Dec-22-25 08:00AM	Vyome Subsidiary LiveChain (LICH) to Acquire Senior Secured Note in Humanyze, An MIT Incubated Company (Business Wire) +5.43%
Dec-08-25 08:00AM	Vyome Reports Positive Final Phase 2 Results for VT-1953; Plans to Advance Into Pivotal Study For FDA Approval (Business Wire) +14.37%
Nov-25-25 07:00AM	Vyome Appoints Renowned Medical Oncologist, Dr. Aditya Bardia, as Senior Medical Advisor to Guide the Development of MFW Program (Business Wire)
07:00AM	Loading…
Nov-18-25 07:00AM	Vyome Holdings Announces Transformational First Quarter Following Nasdaq Listing (Business Wire)
Nov-04-25 09:04AM	Vyome Holdings Announces Results of Annual Shareholder Meeting (Business Wire)
Sep-29-25 07:00AM	Vyome Holdings Acquires MIT AI Spinout Oculo Health (Business Wire)
Sep-17-25 07:00AM	Vyome Presents Strong Data Showing Topical VT-1908 is an Effective Treatment for Uveitis, Opening Up a $3B Addressable Market Opportunity (Business Wire)
Sep-09-25 08:30AM	Vyome Holdings Strengthens Leadership Team with Industry Veterans as it plans Pivotal Trial Studies (Business Wire)
Sep-04-25 08:30AM	Vyome Holdings Announces Positive Interim Data from Phase 2 Study of VT-1953 in Malignant Fungating Wounds (MFW) and Provides Update on MFW market opportunity (Business Wire) -9.06%
Aug-21-25 07:00AM	Vyome Signs MoU with Embryyo, India's Leading Medical Device Innovation Studio (Business Wire) +21.91%
Aug-18-25 08:30AM	Vyome Announces Strategic Review of Livechain (OTCID: LICH) (Business Wire) -37.64%
Aug-15-25 02:57PM	Vyome to leverage US-India ties to tackle $100B immuno-inflammatory market (Investing.com) -10.71%
08:00AM	Vyome To Mark First Day of Trading as HIND with Nasdaq Opening Bell (Business Wire)
07:18PM	Loading…
Aug-14-25 07:18PM	Vyome closes Merger Transaction, Will Trade on Nasdaq as HIND Tomorrow (Business Wire) +22.50%

Vyome Holdings, Inc. engages in the development of immuno-inflammatory assets. It focuses on therapeutic solutions that target formulations for site-targeted applications. The company was founded on January 2, 2008 and is headquartered in San Clemente, CA.

open in yahoo | open in reuters | open in marketwatch | open in google | open in EDGAR

HIND

Vyome Holdings Inc

Upgrade your FINVIZ experience